Parker Waichman LLP Files Injury Lawsuit Against Philips NV And Related Entities On Behalf Of A West Virginia Woman Who Developed Lung Cancer After Using CPAP Machines
- S&P, Nasdaq enjoy boost from big tech firms, Dow ends a hair lower
- Zillow (ZG) Stock Falls on Report Company Paused Home Purchases due to High Demand, a Temporary Halt Yields a Chance for Competitors Says Analyst
- Oil prices pull back as U.S. factory data intensifies demand concerns
- Chip Shortages are Increasingly Becoming a New Bearish Risk, Inflation Bearish for Consumer Electronics - TFI's Kuo
- Walt Disney (DIS) Stock Slips as Barclays Downgrades Amid Disney+ Growth Slowdown
Juilette McKinney vs Koninklijke Philips N.V. et al Civil Action No.: 21-11500, filed in United States District Court, District of Massachusetts
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
PORT WASHINGTON, N.Y., Sept. 21, 2021 /PRNewswire/ -- Parker Waichman LLP, a national law firm, filed a lawsuit on September 13, 2021, against Koninklijke Philips N.V., and subsidiaries, in United States District Court, District of Massachusetts. The lawsuit, claiming failure to warn, design defect and breach of warranty, was filed on behalf of Juilette McKinney, of Midway, West Virginia, alleges that Ms. McKinney developed lung cancer as a direct result of her daily use of Philips' continuous positive airway pressure ("CPAP") devices: a System One RemStar Auto CPAP and a DreamStation Auto CPAP.
Ms. McKinney's physician prescribed the devices for obstructive sleep apnea (OSA), a breathing disorder that can result in snoring, fatigue, and cardiovascular conditions. CPAP devices deliver filtered, pressurized air through a mask, holding a patient's airway open.
On June 14, 2021, Philips announced a recall of millions of CPAP devices, including the two devices used by Ms. McKinney for obstructive sleep apnea (OSA). On July 29, 2021, the FDA classified the recall as Class I, the most serious recall classification which involves the potential for the risk of serious injury or death. Since 2009, Philips has used a polyester-based polyurethane ("PE-PUR") foam in the recalled devices.
In announcing the recall, Philips admitted that the PE-PUR foam potentially exposes users to critical safety risks, including "possible toxic and carcinogenic effects," when the foam degrades. The lawsuit maintains that Philips knew or should have known about the risks from PE-PUR foam degradation long before it notified the public in 2021. An adverse event report in the FDA database shows a patient complaining of "black dust" as early as 2011 and OSA patients regularly reported the presence of black particles in the tubes of their devices on message boards.
The lawsuit seeks damages for Ms. McKinney's severe injuries, as well as punitive damages.
Jerrold S. Parker, founding partner of Parker Waichman LLP, noted that "Philips chose to rush devices to market, without adequately investigating, and disregarded numerous warnings. Ms. McKinney now faces lung cancer. It's time for Philips to answer for its actions."
Filing a CPAP Lawsuit
Parker Waichman has represented clients in injury lawsuits for decades. If you or someone you know is interested in filing a CPAP lawsuit, please call 1-800-YOUR LAWYER or visit the firm's website at https://www.yourlawyer.com
View original content:https://www.prnewswire.com/news-releases/parker-waichman-llp-files-injury-lawsuit-against-philips-nv-and-related-entities-on-behalf-of-a-west-virginia-woman-who-developed-lung-cancer-after-using-cpap-machines-301381856.html
SOURCE Parker Waichman LLP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Weatherford Wins Hart Energy Special Meritorious Award for Engineering Innovation for ForeSite® Edge Next-Generation Automation Technology
- Scottie Resources Appoints CFO
- Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!